NEW YORK, Feb 9 (Reuters) - Oil prices settled more than 1% higher on Monday after the U.S. Department of Transportation issued an advisory to U.S.-flagged vessels to stay as far as possible from ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked. As GLP-1 medications continue to ...

PORT ARTHUR, Texas — The city of Port Arthur plans to launch a new 3-1-1 non-emergency service next month aimed at improving communication between residents and city officials. Starting March 1, ...

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, Reuters ...

X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...

Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...

The Justice Department said late Monday it is still poring through millions of documents that may be related to Jeffrey Epstein, as the Trump administration grapples with a congressional mandate to ...

With GLP-1 use rising across the country, major brands are boosting protein, cutting sugar, and reworking formulations and packaging to fit how shoppers are eating today. Stacey Leasca is an ...

People who take GLP-1 drugs are spending less money on food, according to a new study Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her work has previously ...

The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was successfully dosed in the MEOW-1 study of OKV-119 – an investigational ...

Challenger, Gray & Christmas said layoff plans totaled 71,321 in November, a step down from the massive cuts announced in October but still enough to bring the 2025 total up to 1.17 million. The ...